S-verapamil

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameS-verapamil
Drug Alias NameLevoverapamilD-2024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionCoronary Artery DiseaseAngina Pectoris +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb
Active IndicationsN/A
Inactive IndicationsHypertensionCoronary Artery DiseaseAngina Pectoris +[4

Other Information

ATC CodeN/A
Related LinksN/A